6861-61-6

Basic information

• Product Name: Cyclobutanethiol
• Synonyms: Cyclobutanethiol
• CAS NO: 6861-61-6
• Molecular Formula: C₄H₈S
• Molecular Weight: 88.17
• Mol File: 6861-61-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 101-103 °C
• Appearance: /
• Density: 0.97±0.1 g/cm3(Predicted)
• PKA: 10.87±0.20(Predicted)
• CAS DataBase Reference: Cyclobutanethiol(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutanethiol(6861-61-6)
• EPA Substance Registry System: Cyclobutanethiol(6861-61-6)

Safety Data

• Hazardous Substances Data: 6861-61-6(Hazardous Substances Data)

Usage

General Description

Cyclobutanethiol, also known as 1-Thia-3-azaspiro[4.4]nonan-4-one among other names, is a chemical compound of composition C4H8S. It is known for its strong, unpleasant odor and is normally a light yellow liquid at room temperature. It falls into the category of organosulfur compounds, characterized by the presence of sulfur, and is an alcohol derivative of cyclobutane. It is most commonly used in scientific research, especially in the field of organic chemistry. Its CAS Registry Number, a unique identifier for chemical substances, is 3018-12-0.

Upstream product

• 4399-47-7 Bromocyclobutane 
• 10437-85-1 cyclobutyl 4-methylbenzenesulfonate 

Relevant articles and documents

SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF

A compound is shown in formula (I). The derivatives of the compound include a stereoisomer, a pharmaceutically acceptable salt, a solvate, a prodrug, a metabolite, a deuterated derivative. The compound is a structurally novel substituted imidazole formate derivative. Substituted imidazole formate derivatives are used in preparing a drug with sedative, hypnotic and/or anesthetic effects, as well as a drug that can control the state of epilepsy. The compound has a good inhibitory effect on the central nervous system, and provides a new option for clinical screening of and/or preparation of a drug with sedative, hypnotic and/or anesthetic effects and controlling the state of epilepsy.

HETEROARYLS AMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATORS

The present invention provides Formula (1A) compounds that act as glucokinase activators; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by glucokinase. X, Y, Z, R1, R2, R3, and R4 are as described herein.